Cargando…

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes

Genetic polymorphism in the interferon lambda (IFN-λ) region is associated with spontaneous clearance of hepatitis C virus (HCV) infection and response to interferon-based treatment. Here, we evaluate associations between IFN-λ polymorphism and HCV variation in 8729 patients (Europeans 77%, Asians 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaturvedi, Nimisha, Svarovskaia, Evguenia S, Mo, Hongmei, Osinusi, Anu O, Brainard, Diana M, Subramanian, G Mani, McHutchison, John G, Zeuzem, Stefan, Fellay, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2019
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721370/ https://www.ncbi.nlm.nih.gov/pubmed/31478832 http://dx.doi.org/10.7554/eLife.42542

Ejemplares similares

Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage
por: Hostager, Reilly, et al.
Publicado: (2019)

The emergence of NS5B resistance associated substitution S282T after sofosbuvir‐based treatment
por: Gane, Edward J., et al.
Publicado: (2017)

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
por: Ansari, M Azim, et al.
Publicado: (2019)

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt
por: Shiha, Gamal, et al.
Publicado: (2019)

Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir
por: Martin, Ross, et al.
Publicado: (2021)

Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes
por: Lang Kuhs, Krystle A., et al.
Publicado: (2015)

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
por: Lawitz, Eric, et al.
Publicado: (2015)

Correcting for Population Stratification Reduces False Positive and False Negative Results in Joint Analyses of Host and Pathogen Genomes
por: Naret, Olivier, et al.
Publicado: (2018)

Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C
por: Susser, Simone, et al.
Publicado: (2014)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

Adaptation on a genomic scale
por: Bartha, István, et al.
Publicado: (2015)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Genetics of the Human Interferon Lambda Region
por: Prokunina-Olsson, Ludmila
Publicado: (2019)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification
por: Hedskog, Charlotte, et al.
Publicado: (2019)

Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
por: Sorrentino, Leonardo, et al.
Publicado: (2022)

Learning is enhanced by tailoring instruction to individual genetic differences
por: Mets, David G, et al.
Publicado: (2019)

Lambda Interferons: New Cytokines with Old Functions
por: Hamming, Ole J., et al.
Publicado: (2010)

Interferon Lambda: Modulating Immunity in Infectious Diseases
por: Syedbasha, Mohammedyaseen, et al.
Publicado: (2017)

Macrophage Coordination of the Interferon Lambda Immune Response
por: Read, Scott A., et al.
Publicado: (2019)

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases
por: Wallace, Jonathan W., et al.
Publicado: (2021)

Interferon lambda in inflammation and autoimmune rheumatic diseases
por: Goel, Rishi R., et al.
Publicado: (2021)

Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
por: Oleinik, L. A., et al.
Publicado: (2023)

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent
por: Hillyer, P, et al.
Publicado: (2013)

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent
por: Hillyer, Philippa, et al.
Publicado: (2012)

Early Treatment with Pegylated Interferon Lambda for Covid-19
por: Reis, Gilmar, et al.
Publicado: (2023)

Complete Genome Sequences of Lambdoid Phages 21, 434, and 434B and Several Lambda Hybrids
por: Feiss, Mike, et al.
Publicado: (2022)

Interferon Lambda: A New Sword in Cancer Immunotherapy
por: Lasfar, Ahmed, et al.
Publicado: (2011)

Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo
por: Hermant, Pascale, et al.
Publicado: (2014)

Interferon Lambda Genetics and Biology in Regulation of Viral Control
por: Hemann, Emily A., et al.
Publicado: (2017)

The Characteristics of Heterozygous Protein Truncating Variants in the Human Genome
por: Bartha, István, et al.
Publicado: (2015)

Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
por: Santer, Deanna M., et al.
Publicado: (2020)

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients
por: Phillips, Sandra, et al.
Publicado: (2017)

Clinical Observation and Genotype-Phenotype Analysis of ABCA4-Related Hereditary Retinal Degeneration before Gene Therapy
por: Xiao, Xuan, et al.
Publicado: (2022)

Interleukin-28B genotype testing to determine response to the combination of pegylated-interferon and ribavirin for the treatment of hepatitis C virus
por: Nguyen, Christine M., et al.
Publicado: (2011)

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
por: Bellanti, F., et al.
Publicado: (2012)

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
por: Novotny, Laura A., et al.
Publicado: (2021)

Interferon-lambda as a new approach for treatment of allergic asthma?
por: Edwards, Michael R, et al.
Publicado: (2011)

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV
por: Laidlaw, Stephen M., et al.
Publicado: (2014)

Interferon lambda inhibits dengue virus replication in epithelial cells
por: Palma-Ocampo, Helen K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ruf3v2mmpq8puvrd2gojs5stas